Almanac Life Science India Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 8 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
About Almanac Life Science India
Almanac Life Science India Private Limited (ALSIPL) is a Private Limited Indian Non-Government Company incorporated in India on 01 August 2016 (Eight years and six months 0 days old ). Its registered office is in Delhi, India.
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Mohammed Tarique and Shah Arjoo serve as directors at the Company.
Company Details
- Location
Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U74999DL2016PTC303853
- Company No.
303853
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
01 Aug 2016
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
What products or services does Almanac Life Science India Private Limited offer?
Almanac Life Science India Private Limited offers a wide range of products and services, including Flavours & Aromatics, Food Enzymes, Industrial Chemicals & Supplies, Speciality Chemicals.
Who are the key members and board of directors at Almanac Life Science India?
Executive Team (1)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Mohammed Tarique | Managing Director | 01-Aug-2016 | Current |
Board Members (1)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Shah Arjoo | Director | 01-Aug-2016 | Current |
Financial Performance of Almanac Life Science India.
Almanac Life Science India Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue | |||||||
Revenue from Operations | |||||||
Total Assets | |||||||
Profit or Loss | |||||||
Net Worth | |||||||
EBITDA |
What is the Ownership and Shareholding Structure of Almanac Life Science India?
In 2017, Almanac Life Science India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Almanac Life Science India?
Unlock and access historical data on people associated with Almanac Life Science India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Almanac Life Science India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Almanac Life Science India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.